Trial Profile
A prospective, open label study to investigated the safety and steady state pharmacokinetics of Cortexolone 17a-propionate (CB-03-01; 1 % cream) in patients with with moderate to severe acne vulgaris.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Clascoterone (Primary)
- Indications Acne vulgaris
- Focus Adverse reactions; Pharmacodynamics
- 10 Dec 2015 New trial record